Home › Funds › Affinity Asset Advisors, LLC › ORKA

Affinity Asset Advisors, LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Affinity Asset Advisors, LLC reported holding 600,000 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$50.0M, representing 2.33% of its reported portfolio and ranking #9 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ORKA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)600.00K sh
Reported value held$49.97M
Portfolio Weight2.33%
First reportedQ3 2024
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's ORKA position evolved

Affinity Asset Advisors, LLC first disclosed a stake in ORKA in Q3 2024 at 349,836 shares (US$8.6M). The position peaked in Q2 2026 at 590,000 shares, worth US$56.2M. Across 9 filings, Affinity Asset Advisors, LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 600,000 shares valued at US$50.0M — an increase of 10,000 shares quarter over quarter.. Notable position changes include a 48% increase in Q1 2025 (shares rose 9% over the following quarter), a 59% increase in Q3 2025 (shares rose 58% over the following quarter), a 38% trim in Q1 2026 (shares rose 94% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 349.84K $8.57M New
Q4 2024 368.70K $7.15M Add
Q1 2025 545.36K $5.60M Add
Q2 2025 603.48K $6.76M Add
Q3 2025 959.18K $18.45M Add
Q4 2025 802.34K $24.32M Reduce
Q1 2026 499.67K $24.51M Reduce
Q2 2026 590.00K $56.15M Add
Q3 2026 600.00K $49.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held ORKA?

Affinity Asset Advisors, LLC has disclosed ORKA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Affinity Asset Advisors, LLC's current position in ORKA?

As of Q3 2026, Affinity Asset Advisors, LLC holds 600.00K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $49.97M, representing 2.33% of its reported portfolio and ranking #9.

Has Affinity Asset Advisors, LLC been buying or selling ORKA?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in ORKA. The position peaked in Q2 2026 at 590.00K shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 86 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.